Synthesis of Ultrasmall Superparamagnetic Iron Oxides Using Reduced Polysaccharides

Bioconjugate Chemistry

Volumn 15, Issue 2, 2004, Pages 394-401

  Paul, Kenneth G ^a,b   Frigo, Timothy B ^a   Groman, Jesse Y ^a,c   Groman, Ernest V ^a,b  

^a Advanced Magnetics Inc   (United States)

^b BioPhysics Assay Laboratory Inc   (United States)

^c Safeco Insurance Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COATINGS; IRON OXIDES; MAGNETIC BUBBLES; MAGNETIC SUSCEPTIBILITY; MOLECULAR WEIGHT; PARTICLE SIZE; STABILITY; SUPERPARAMAGNETISM;

% REDUCTIONS; COATING STABILITY; IRON OXIDE PARTICLES; LARGE PARTICLES; LOW MOLECULAR WEIGHT; PARTICLE FORMATIONS; PARTICLE SYNTHESIS; PARTICLES SIZES; REDUCING SUGARS; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

DEXTRAN;

CARBOHYDRATE; DEXTRAN; IRON; POLYSACCHARIDE; PULLULAN; SUGAR; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADSORPTION; ARTICLE; AUTOCLAVE; MAGNETISM; MATERIAL COATING; MOLECULAR STABILITY; MOLECULAR WEIGHT; PARTICLE SIZE; REDUCTION; SYNTHESIS;

EID: 1642269075     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034194u     Document Type: Article

References (23)

1. Weissleder, R., Elizondo, G., Wittenberg, J., Rabito, C. A., Bengele, H. H., and Josephson, L. (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175, 489-493
2. Jung, C. W., and Jacobs, P. (1995) Physical and chemical properties of superparamagnetic iron oxide MR constrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imag. 13 (5), 661-674.
3. Hasegawa, M., Hanaichi, T., Shoji, H., Kawaguchi, T., and Maruno, S. (1998) Biological behavior of dextran-iron oxide magnetic fluid injected intravenously in rats. Jpn. J. App. Phys., Part 137 (3A), 1029-1032.
4. Anzai, Y., Prince, M. R., Chenervert, T. L., Maki, J. H., Londy, F., London, M., and McLachlan, S. J. (1997) MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn. Reson. Imag. 7 (1), 209-214.
5. Mühler, A., Zhang, X., Wang, H., Lawaczeck, R., and Weinmann, H-J. (1995) Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes. Invest. Radiol. 30, 98-103.
6. Bellin, M. F., Roy, C., Kinkel, K., Thoumas, D., Zaim, S., Vanel, D., Tuchmann, C., Richard, F., Jacqmin, D., Delcourt, A., Challier, E., Lebret, T., and Cluzel, P. (1998) Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 207 (3), 799-808.
7. Shen, T. T., Bogdanov, A., Jr., Bogdanova, A., Poss, K., Brady, T. J., and Weissleder, R. (1996) Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. Bioconjugate Chem. 7 (3), 311-316.
8. Weissleder, R., Lee, A. S., Fischman, A. J., Reimer, P., Shen, T., Wilkenson, R., Callahan, R. J., and Brady, T. J. (1991) Polyclonal human immunoglobulin G Labeled with Polymeric Iron Oxide: antibody MR imaging. Radiology 181 (1), 245-249.
9. Devineni, D., Blanton, C. D., and Gallo, J. M. Preparation and in vivo evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems. (1995) Bioconjugate Chem. 6, 203-210
10. Jordan, A., Scoltz, R., Fähling, H., Krause, J., Konstanczak, P., Woldarzyk, W., Sander, B., Vogl, T., and Felix, R. (1996) Effects of magnetic fluid hyperthemia (MFH) on C3H mammary carcinoma in vivo. Int. J. Hyperthemia 6, 1-20.
11. Autenshlysus, A. I., Bruesentov, N. A., and Lockshin, A. (1993) J. Magn. Mater. 122, 360-363.
12. Schütt, W., Grüttner, C., Häfeli, U., Zborowski, M., Teller, J., Putzar, H., and Schümichen, C. (1997) Applications of Magnetic Targeting in Diagnosis and Therapy-Possibilities and Limitations: A Mini-Review. Hybridoma 16, 109-117.
13. Kresse, M., Wagner, S., Pfefferer, D., Lawaczeck, R., Elste, V., and Semmler, W. (1998) Targeting of ultrasmall superparamagnetic iron oxide particles to tumor cells in vivo by using transferrin receptor pathways. Magn. Reson. Med. 40, 236-242.
14. Kumar, K. (1997) Iron assay and size exclusion high performance liquid chromatography of ferritin and magnetoferritin. J. Liq. Chromatogr. Relat. Technol. 20, 3351-3364.
15. Jue, C. K., and Lipke, P. N. (1985) Determination of reducing sugars in the nanomole range with tetrazolium blue. J. Biochem. Biophys. Methods 11, 109-115.
16. Kitchen, R. (1983), Total polysaccharide test and quantitative method for dextran analysis. Proc. Sugar Process. Res. Conf 232-247.
17. Gyozo, B. (1974) Organic Chemistry. Amino Acids, Peptides and Carbohydrates, p 991, Tankonykiado Press, Budapest.
18. Hasagawa, M. et al. (1995) U.S. Patent 5,424,419.
19. Herb, J. R. (1977) U.S. Patent 4,180,567.
20. Hlady, V., Lykelema, J., and Fleer, G. J. (1982) Effect of polydispersity on the adsorption of dextran on silver iodide. J. Colloid Interace Sci. 87, 395-406.
21. Gulyas, G., unpublished results from Advanced Magnetics, Inc.
22. Tadros, Th. F. (1982) Polymer Adsorption and Dispersion Stability. The Effect of Polymers on Dispersion Properties (Th. F. Tadros, Ed.) pp 1-38, Academic Press, New York.
23. Laidler, K (1965) Chemical Kinetics, pp 267-269, McGraw-Hill Book Company, New York.